CA
Continental Advisors Portfolio holdings
AUM
$140M
This Quarter Return
+5.85%
1 Year Return
+10.45%
3 Year Return
+26.28%
5 Year Return
+49.35%
10 Year Return
+58.99%
AUM
$111M
AUM Growth
+$111M
(+0.15%)
Cap. Flow
-$15.7M
Cap. Flow
% of AUM
-14.15%
Top 10 Holdings %
Top 10 Hldgs %
52.47%
Holding
40
New
–
Increased
7
Reduced
19
Closed
3
Top Buys
| 1 |
Northern Trust
NTRS
|
$1.65M |
| 2 |
Western Union
WU
|
$834K |
| 3 |
Regions Financial
RF
|
$465K |
| 4 |
Federated Hermes
FHI
|
$271K |
| 5 |
Perrigo
PRGO
|
$221K |
Top Sells
| 1 |
Uber
UBER
|
$3.2M |
| 2 |
Invesco
IVZ
|
$2.37M |
| 3 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$2.26M |
| 4 |
Cardinal Health
CAH
|
$1.75M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
$1.38M |
Sector Composition
| 1 | Financials | 40.36% |
| 2 | Healthcare | 28.31% |
| 3 | Technology | 9.56% |
| 4 | Consumer Discretionary | 3.95% |
| 5 | Energy | 2.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Uber
UBER
$196B
| $10.6M | 4.14% |
172,148
-52,000
| -23% | -$3.2M |
|
2
Capital One
COF
$145B
| $7.12M | 2.78% |
54,310
-8,500
| -14% | -$1.11M |
|
3
Viatris
VTRS
$12.3B
| $6.48M | 2.53% |
597,889
-33,500
| -5% | -$363K |
|
4
Gilead Sciences
GILD
$140B
| $6.07M | 2.37% |
74,903
-7,000
| -9% | -$567K |
|
5
Pfizer
PFE
$141B
| $5.98M | 2.33% |
207,792
-42,500
| -17% | -$1.22M |
|
|
6
Western Union
WU
$2.8B
| $5.11M | 2% |
429,090
+70,000
| +19% | +$834K |
|
7
Cannae Holdings
CNNE
$1.09B
| $4.38M | 1.71% |
224,535
+1,000
| +0.4% | +$19.5K |
|
8
Wells Fargo
WFC
$263B
| $4.33M | 1.69% |
87,906
+3,500
| +4% | +$172K |
|
|
9
Perrigo
PRGO
$3.27B
| $4.27M | 1.67% |
132,632
+6,854
| +5% | +$221K |
|
|
10
Northern Trust
NTRS
$25B
| $3.82M | 1.49% |
45,301
+19,500
| +76% | +$1.65M |
|
11
Alerian MLP ETF
AMLP
$10.7B
| $3.67M | 1.43% |
86,223
-12,000
| -12% | -$510K |
|
12
Energy Select Sector SPDR Fund
XLE
$27.6B
| $3.61M | 1.41% |
43,000
| – | – |
|
13
Truist Financial
TFC
$60.4B
| $3.6M | 1.4% |
97,450
-2,000
| -2% | -$73.8K |
|
|
14
Invesco
IVZ
$9.76B
| $3.5M | 1.37% |
196,354
-132,717
| -40% | -$2.37M |
|
15
Teva Pharmaceuticals
TEVA
$21.1B
| $3.29M | 1.28% |
314,866
-26,000
| -8% | -$271K |
|
|
16
Federated Hermes
FHI
$4.12B
| $3.2M | 1.25% |
94,542
+8,000
| +9% | +$271K |
|
17
iShares MSCI Singapore ETF
EWS
$792M
| $3.08M | 1.2% |
164,774
| – | – |
|
18
Goldman Sachs
GS
$226B
| $3.01M | 1.17% |
7,793
-1,500
| -16% | -$579K |
|
19
Shell
SHEL
$215B
| $2.8M | 1.09% |
42,520
-9,000
| -17% | -$592K |
|
20
JPMorgan Chase
JPM
$829B
| $2.66M | 1.04% |
15,635
| – | – |
|
21
Brookdale Senior Living
BKD
$1.83B
| $2.65M | 1.03% |
454,744
-125,245
| -22% | -$729K |
|
|
22
Cardinal Health
CAH
$35.5B
| $2.54M | 0.99% |
25,184
-17,400
| -41% | -$1.75M |
|
|
B
23
Barrick Mining Corporation
B
$45.4B
| $2.33M | 0.91% |
128,817
-16,450
| -11% | -$298K |
|
24
Citigroup
C
$178B
| $2.13M | 0.83% |
41,434
-8,000
| -16% | -$412K |
|
|
25
SPDR S&P Biotech ETF
XBI
$5.07B
| $1.94M | 0.76% |
21,700
-15,500
| -42% | -$1.38M |
|